Biopejs-shop.dk ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.9% 3.2% 1.3% 1.5% 1.5%  
Credit score (0-100)  58 54 79 75 77  
Credit rating  BBB BBB A A A  
Credit limit (kDKK)  0.0 0.0 231.0 116.5 129.8  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  5,984 10,446 12,073 14,813 14,629  
EBITDA  1,596 5,952 6,790 8,311 7,663  
EBIT  1,506 5,800 6,515 8,031 7,340  
Pre-tax profit (PTP)  1,510.7 5,776.2 6,479.5 8,061.7 7,463.3  
Net earnings  1,176.9 4,499.5 5,049.3 6,271.8 5,808.0  
Pre-tax profit without non-rec. items  1,511 5,776 6,480 8,062 7,463  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  733 1,450 1,175 943 2,004  
Shareholders equity total  2,687 6,966 11,788 16,560 21,368  
Interest-bearing liabilities  229 90.5 54.3 737 92.8  
Balance sheet total (assets)  4,839 10,797 18,007 22,380 26,287  

Net Debt  -723 -2,745 -6,344 -3,932 -5,461  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,984 10,446 12,073 14,813 14,629  
Gross profit growth  44.3% 74.6% 15.6% 22.7% -1.2%  
Employees  12 11 12 12 12  
Employee growth %  0.0% -8.3% 9.1% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,839 10,797 18,007 22,380 26,287  
Balance sheet change%  52.6% 123.1% 66.8% 24.3% 17.5%  
Added value  1,596.1 5,952.1 6,790.2 8,306.0 7,662.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -57 564 -550 -330 662  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  25.2% 55.5% 54.0% 54.2% 50.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  37.9% 74.2% 45.3% 39.9% 30.7%  
ROI %  59.9% 112.9% 68.6% 55.2% 38.5%  
ROE %  54.7% 93.2% 53.8% 44.2% 30.6%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  55.5% 66.4% 67.8% 74.8% 81.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -45.3% -46.1% -93.4% -47.3% -71.3%  
Gearing %  8.5% 1.3% 0.5% 4.4% 0.4%  
Net interest  0 0 0 0 0  
Financing costs %  2.6% 14.9% 53.4% 0.7% 3.1%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  1.1 1.5 1.9 2.7 3.0  
Current Ratio  2.2 2.5 2.7 5.2 6.9  
Cash and cash equivalent  951.7 2,835.1 6,398.5 4,668.3 5,553.8  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  2,204.7 5,571.6 10,657.6 17,122.3 20,680.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  133 541 566 692 639  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  133 541 566 693 639  
EBIT / employee  126 527 543 669 612  
Net earnings / employee  98 409 421 523 484